Organisation
M42's Insights Research Organisation leads Alzheimer's therapy trials
HT-4253 will be tested on Emiratis at risk of Alzheimer’s using data from the Emirati Genome Programme, marking a shift toward early‑stage intervention.
2 Jul 2026